Helsinn was originally founded as an in-licensing company 40 years ago. Thanks to this heritage, we have decades of expertise in identifying and sourcing innovative NCEs in the early to late stage of development, then taking them through the full clinical development program and towards registration, commercialization and distribution.
Expertise and credibility
We have a trusted record taking NCEs and using our integrated capabilities and in-house knowledge to complete development, from pre-clinical and clinical studies through to securing market approval worldwide and commercialization. Our high quality internal R&D, unique focus and network in cancer care give us the infrastructure, the expertise and the credibility to build a lasting franchise.